Electric Countershock

"Electric Countershock" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An electrical current applied to the HEART to terminate a CARDIAC ARRHYTHMIA.

Descriptor ID	D004554
MeSH Number(s)	E02.331.350
Concept/Terms	Electric Countershock Electric Countershock Countershock, Electric Countershocks, Electric Electric Countershocks Defibrillation, Electric Defibrillations, Electric Electric Defibrillation Electric Defibrillations Electrical Cardioversion Cardioversion, Electrical Cardioversions, Electrical Electrical Cardioversions Cardiac Electroversion Cardiac Electroversions Electroversions, Cardiac Electroversion, Cardiac Cardioversion Cardioversions Electroversion Therapy Electroversion Therapy Electroversion Therapies Therapies, Electroversion Therapy, Electroversion

Below are MeSH descriptors whose meaning is more general than "Electric Countershock".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Electric Stimulation Therapy [E02.331]
Electric Countershock [E02.331.350]

Below are MeSH descriptors whose meaning is related to "Electric Countershock".

Below are MeSH descriptors whose meaning is more specific than "Electric Countershock".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Electric Countershock" by people in this website by year, and whether "Electric Countershock" was a major or minor topic of these publications.

Bar chart showing 72 publications over 24 distinct years, with a maximum of 7 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	2	3	5
2003	1	1	2
2004	2	1	3
2005	2	0	2
2006	1	0	1
2007	3	2	5
2008	1	0	1
2009	2	1	3
2010	4	2	6
2012	4	2	6
2013	2	0	2
2014	2	3	5
2015	0	2	2
2016	3	1	4
2017	4	3	7
2018	3	0	3
2019	1	1	2
2020	3	1	4
2021	0	2	2
2022	0	1	1
2023	0	2	2
2024	0	2	2
2025	1	0	1
2026	0	1	1

Below are the most recent publications written about "Electric Countershock" by people in Profiles.

Kramer CM, Kolm P, DiMarco JP, Desai MY, Ho CY, Kwong RY, Dolman SF, Desvigne-Nickens P, Geller N, Kim DY, Schulz-Menger J, Friedrich MG, Maron MS, Appelbaum E, Link MS, Francis GS, Greenberg B, Jerosch-Herold M, Piechnik S, Mahmod M, Raman B, Jacoby DL, Baldassare LA, White JA, Chiribiri A, Helms AS, Choudhury L, Michels M, Bradlow WM, Salerno M, Heitner SB, Masri A, Prasad SK, Mohiddin SA, Plein S, Madias C, Mahrholdt H, Bucciarelli-Ducci C, Nightingale AK, Weinsaft JW, Kim HW, McCann GP, van Rossum A, Germans T, Williamson EE, Geske JB, Flett AS, Dawson D, Mongeon FP, Olivotto I, Crean AM, Woo A, Owens AT, Anderson L, Sharma S, Biagini E, Newby DE, Andre F, Berry C, Kim B, Larose E, Abraham TP, Hays AG, Sherrid MV, Gelfand EV, Nagueh SF, Rimoldi O, Camici P, Elstein E, Autore C, Watkins H, Weintraub WS, Neubauer S. Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry. JAMA. 2026 Jun 09; 335(22):1959-1969.

View in: PubMed
Sawalha K, Alakchar M, Mamas MA, Johnson D, Bhan A, Goldsweig AM. Safety of cardioversion without anticoagulation in patients' status post left atrial appendage occlusion: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2026 03; 84:105-109.

View in: PubMed
Kiani S. Inhaled Oral Flecainide for Rapid Cardioversion of Atrial Fibrillation. JACC Clin Electrophysiol. 2024 06; 10(6):1034-1036.

View in: PubMed
Narayanan CA, Bokhari N, Rowin EJ, Maron MS, Maron BJ, Link MS, Madias C. Maintenance of Subcutaneous Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy Patients With Iatrogenic Left Bundle-Branch Block After Septal Myectomy. J Am Heart Assoc. 2024 04 16; 13(8):e033728.

View in: PubMed
Sink J, Peigh G, Speakman B, Banno J, Sanders D, Nso N, Waits G, Lohrmann G, Elsayed M, Carneiro H, Baman J, Pfenniger A, Patil KD, Arora R, Kim SS, Chicos AB, Lin AC, Passman RS, Knight BP, Dandamudi S, Kaplan RM, Huang H, Wasserlauf J, Verma N. Correlation between high- and low-voltage impedance measurements following subcutaneous implantable cardioverter-defibrillator implantation. Heart Rhythm. 2024 04; 21(4):492-494.

View in: PubMed
Maron MS, Rowin EJ, Bonaventura J, Maron BJ. Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field? Am J Cardiol. 2023 08 01; 200:236-238.

View in: PubMed
Guha A, Jain A, Aggarwal A, Dey AK, Dani S, Ganatra S, Marchlinski FE, Addison D, Fradley MG. Length of stay and cost of care associated with admissions for atrial fibrillation among patients with cancer. BMC Cardiovasc Disord. 2022 06 17; 22(1):272.

View in: PubMed
Gaspari R, Weekes A, Adhikari S, Noble VE, Nomura JT, Theodoro D, Woo MY, Atkinson P, Blehar D, Brown SM, Caffery T, Haines C, Lam S, Lanspa M, Lewis M, Liebmann O, Limkakeng A, Platz E, Moore C, Raio C. Comparison of outcomes between pulseless electrical activity by electrocardiography and pulseless myocardial activity by echocardiography in out-of-hospital cardiac arrest; secondary analysis from a large, prospective study. Resuscitation. 2021 12; 169:167-172.

View in: PubMed
Shannon K, Saltzman D, Li I, Mokszycki R, Galletta G. Ventricular tachycardia converts to sinus rhythm after administration of propofol. Am J Emerg Med. 2021 10; 48:377.e1-377.e3.

View in: PubMed
Shirani J, Aurshiya R, Elshaikh A, Olenchock SA, Rowin EJ, Maron MS, Maron BJ. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices. Am J Cardiol. 2021 03 01; 142:130-135.

View in: PubMed

People

Explore

Similar Concepts

Top Journals